| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2578083 | Revista del Laboratorio Clínico | 2014 | 5 Pages |
Abstract
Blood IFX and HACA concentrations should be monitored in patients receiving IFX, as it may be useful to optimize dose regimens or avoid use of inadequate therapy.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Clinical Biochemistry
Authors
Adriana Rivero Marcotegui, Rosario Ibañez Bosch, Andrés Zuñiga Vera, Antonio ArÃn Letamendia, MarÃa Jesús Burusco Paternain,